𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Characterization of 11 novel mutations in the X-linked chronic granulomatous disease (CYBB gene)

✍ Scribed by Bénédicte Gérard; Jamel El Benna; Françoise Alcain; Marie-Anne Gougerot-Pocidalo; Bernard Grandchamp; Sylvie Chollet-Martin


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
19 KB
Volume
18
Category
Article
ISSN
1059-7794

No coin nor oath required. For personal study only.

✦ Synopsis


The most frequent form of chronic granulomatous disease (CGD) is caused by inactivation of the CYBB gene, which encodes the gp91-phox subunit of phagocyte NADPH oxidase. This defect prevents phagocytes from producing reactive oxygen species and thus from eradicating bacterial and fungal infections. We investigated 16 unrelated male patients with suspected X-linked CGD and gp91-phox deficiency. A mutation was found in the CYBB gene of all 16 patients, and 11 of these mutations were novel. Eleven patients (69%) had a point mutation (84G>A in two unrelated patients, and 177C>G, 217C>T, 388C>T, 676C>T, 691C>T, 868C>T, 919A>C, 1384G>T and T1514G in one case each, yielding W28X, C59W, R73X, R130X, R226X, Q231X, R290X, T307P, E462X, L505R gp-91phox). One patient had an in-frame deletion removing two amino acids (R54 and A55). Finally, insertions or duplications were found in four patients (from +1 to +31 bases). Overall, 12 (75%) of the mutations led to the production of a truncated protein. No clear correlation was found between clinical manifestations and genomic/biochemical alterations. Thirteen mothers could be tested, and all were carriers.


📜 SIMILAR VOLUMES


Identification and functional characteri
✍ Bernadette Boog; Alex Quach; Maurizio Costabile; Joanne Smart; Patrick Quinn; Ha 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 270 KB

Chronic granulomatous disease (CGD) is mainly caused by mutations in X-linked CYBB that encodes gp91. We have identified two novel mutations in CYBB resulting in the rare X91 + -CGD variant, c.1500T>G (p.Asp500Glu) in two male siblings and c.1463C>A (p.Ala488Asp) in an unrelated male. Zymosan and/or

Novel mutations in the connexin 32 gene
✍ Charles C. Tan; Peter J. Ainsworth; Angelika F. Hahn; Patrick M. MacLeod 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB 👁 2 views

by R d G. Worton Charcot-Marie tooth disease, a pathologically and genetically heterogeneous group of disorders that causes a progressive neuropathy, is characterized by weakness and atrophy, primarily in peroneal and distal leg muscles. It is defined patholog-Mutation leads to 10s:. of this Mae 111

A novel mutation of gap junction protein
✍ Sheng Dong Chen; Zheng Xi Li; Yang Tai Guan; Xia Jun Zhou; Jian Ming Jiang; Yong 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

## Abstract Introduction: In this study we report a novel mutation in the gap junction protein beta 1 (__GJB1__) gene of a Chinese X‐linked Charcot–Marie–Tooth disease (CMTX1) family, which has specific electrophysiological characteristics. Methods: Twenty members in the family were studied by clin

Genetic and clinical aspects of X-linked
✍ Sabine Weller; Jutta Gärtner 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 295 KB

L1 disease is a group of overlapping clinical phenotypes including X-linked hydrocephalus, MASA syndrome, spastic paraparesis type 1, and X-linked agenesis of corpus callosum. The patients are characterized by hydrocephalus, agenesis or hypoplasia of corpus callosum and corticospinal tracts, mental

Identification of nine novel mutations i
✍ Paola Orlandi; Kostas Ritis; Viviana Moschese; Federica Angelini; Konstantinos A 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB 👁 2 views

## Mutations in the Bruton's tyrosine kinase (BTK ) gene are responsible for X-linked Agammaglobulinemia (XLA), an immunodeficiency caused by a block in B cell differentiation. Non Isotopic RNAse Cleavage Assay (NIRCA), followed by sequencing was used to screen for BTK mutations in 11 Italian XLA p